Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Генеральні виробники лікарських засобів

Dr. Dean Y. Li M.D., Ph.D.

Executive Vice President & Pres of Merck Research Laboratories

Ms. Caroline  Litchfield

Executive Vice President & Chief Financial Officer

Mr. Robert M. Davis J.D.

Chief Executive Officer & Chairman

Mr. Steven C. Mizell

Executive Vice President & Chief HR Officer

Chairman, Pres & Chief Executive Officer

Ms. Jennifer  Mauer

Vice President of Global Communications

Ms. Cristal N. Downing

Executive Vice President and Chief Communications & Public Affairs Officer

Mr. Kenneth C. Frazier

Executive Chairman

Mr. Richard R. DeLuca Jr.

Executive Vice President & Pres of Merck Animal Health

Mr. David Michael Williams

Executive Vice President and Chief Information & Digital Officer

Ms. Jennifer L. Zachary

Executive Vice President & Gen. Counsel

Pres, Chief Executive Officer & Director

Lisa  LeCointe-Cephas

Senior Vice President and Chief Ethics & Compliance Officer

Mr. Peter  Dannenbaum

Vice President of Investor Relations

Mr. Chirfi  Guindo

Senior Vice President & Chief Marketing Officer for Merck Human Health

Назва	Ринкова капіталізація
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	0M
Otsuka Holdings Co., Ltd.	0M
Amgen Inc.	0M
Hunan Jingfeng Pharmaceutical Co.,Ltd.	0M
JCR Pharmaceuticals Co., Ltd.	0M
Bristol-Myers Squibb Company	0M
GSK plc	0M
Luye Pharma Group Ltd.	0M
Mayne Pharma Group Limited	0M
Horizon Therapeutics Public Limited Company	0M

Merck & Co., Inc.

Merck & Co., Inc. Список конкурентів

Основні конкуренти